135 related articles for article (PubMed ID: 19037975)
1. Expression of Pla2g2a prevents carcinogenesis in Muc2-deficient mice.
Fijneman RJ; Peham JR; van de Wiel MA; Meijer GA; Matise I; Velcich A; Cormier RT
Cancer Sci; 2008 Nov; 99(11):2113-9. PubMed ID: 19037975
[TBL] [Abstract][Full Text] [Related]
2. Pla2g2a attenuates colon tumorigenesis in azoxymethane-treated C57BL/6 mice; expression studies reveal Pla2g2a target genes and pathways.
Fijneman RJ; Bade LK; Peham JR; van de Wiel MA; van Hinsbergh VW; Meijer GA; O'Sullivan MG; Cormier RT
Cell Oncol; 2009; 31(5):345-56. PubMed ID: 19759415
[TBL] [Abstract][Full Text] [Related]
3. Interaction of Muc2 and Apc on Wnt signaling and in intestinal tumorigenesis: potential role of chronic inflammation.
Yang K; Popova NV; Yang WC; Lozonschi I; Tadesse S; Kent S; Bancroft L; Matise I; Cormier RT; Scherer SJ; Edelmann W; Lipkin M; Augenlicht L; Velcich A
Cancer Res; 2008 Sep; 68(18):7313-22. PubMed ID: 18794118
[TBL] [Abstract][Full Text] [Related]
4. Expression of group IIA phospholipase A2 is an independent predictor of favorable outcome for patients with gastric cancer.
Wang X; Huang CJ; Yu GZ; Wang JJ; Wang R; Li YM; Wu Q
Hum Pathol; 2013 Oct; 44(10):2020-7. PubMed ID: 23664539
[TBL] [Abstract][Full Text] [Related]
5. Secretory type II phospholipase A2 (PLA2G2A) expression status in colorectal carcinoma derived cell lines and in normal colonic mucosa.
Praml C; Amler LC; Dihlmann S; Finke LH; Schlag P; Schwab M
Oncogene; 1998 Oct; 17(15):2009-12. PubMed ID: 9788445
[TBL] [Abstract][Full Text] [Related]
6. Secretory phospholipase A
Kuefner MS; Deng X; Stephenson EJ; Pham K; Park EA
FASEB J; 2019 Jan; 33(1):738-749. PubMed ID: 30020829
[TBL] [Abstract][Full Text] [Related]
7. Thyroid hormone status regulates the expression of secretory phospholipases.
Sharma P; Levesque T; Boilard E; Park EA
Biochem Biophys Res Commun; 2014 Jan; 444(1):56-62. PubMed ID: 24440706
[TBL] [Abstract][Full Text] [Related]
8. Suppression of mucin 2 enhances the proliferation and invasion of LS174T human colorectal cancer cells.
Bu X; Li L; Li N; Tian X; Huang P
Cell Biol Int; 2011 Nov; 35(11):1121-9. PubMed ID: 21605079
[TBL] [Abstract][Full Text] [Related]
9. Identification of the MUC2 Promoter as a Strong Promoter for Intestinal Gene Expression through Generation of Transgenic Quail Expressing GFP in Gut Epithelial Cells.
Woodfint RM; Chen PR; Ahn J; Suh Y; Hwang S; Lee SS; Lee K
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106824
[TBL] [Abstract][Full Text] [Related]
10. Human cancer xenografts in outbred nude mice can be confounded by polymorphisms in a modifier of tumorigenesis.
Zeineldin M; Jensen D; Paranjape SR; Parelkar NK; Jokar I; Vielhauer GA; Neufeld KL
Genetics; 2014 Aug; 197(4):1365-76. PubMed ID: 24913681
[TBL] [Abstract][Full Text] [Related]
11. The roles of sPLA2-IIA (Pla2g2a) in cancer of the small and large intestine.
Fijneman RJ; Cormier RT
Front Biosci; 2008 May; 13():4144-74. PubMed ID: 18508504
[TBL] [Abstract][Full Text] [Related]
12. Mucin Muc2 deficiency and weaning influences the expression of the innate defense genes Reg3β, Reg3γ and angiogenin-4.
Burger-van Paassen N; Loonen LM; Witte-Bouma J; Korteland-van Male AM; de Bruijn AC; van der Sluis M; Lu P; Van Goudoever JB; Wells JM; Dekker J; Van Seuningen I; Renes IB
PLoS One; 2012; 7(6):e38798. PubMed ID: 22723890
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of p21WAF1/cip1 enhances intestinal tumor formation in Muc2-/- mice.
Yang W; Velcich A; Lozonschi I; Liang J; Nicholas C; Zhuang M; Bancroft L; Augenlicht LH
Am J Pathol; 2005 Apr; 166(4):1239-46. PubMed ID: 15793302
[TBL] [Abstract][Full Text] [Related]
14. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa.
Bergstrom KS; Kissoon-Singh V; Gibson DL; Ma C; Montero M; Sham HP; Ryz N; Huang T; Velcich A; Finlay BB; Chadee K; Vallance BA
PLoS Pathog; 2010 May; 6(5):e1000902. PubMed ID: 20485566
[TBL] [Abstract][Full Text] [Related]
15. Elevated adenomatous polyposis coli in goblet cells is associated with inflammation in mouse and human colon.
Gomez CL; Neufeld KL
Exp Physiol; 2020 Dec; 105(12):2154-2167. PubMed ID: 33150708
[TBL] [Abstract][Full Text] [Related]
16. Consequence of distinctive expression of MUC2 in colorectal cancers: How much is actually bad?
Gundamaraju R; Chong WC
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188579. PubMed ID: 34139275
[TBL] [Abstract][Full Text] [Related]
17. Hath1 inhibits proliferation of colon cancer cells probably through up-regulating expression of Muc2 and p27 and down-regulating expression of cyclin D1.
Zhu DH; Niu BL; Du HM; Ren K; Sun JM; Gong JP
Asian Pac J Cancer Prev; 2012; 13(12):6349-55. PubMed ID: 23464457
[TBL] [Abstract][Full Text] [Related]
18. Pla2g2a promotes innate Th2-type immunity lymphocytes to increase B1a cells.
Shinton SA; Brill-Dashoff J; Hayakawa K
Sci Rep; 2022 Sep; 12(1):14899. PubMed ID: 36050343
[TBL] [Abstract][Full Text] [Related]
19. Secretory phospholipase A
Kuefner MS; Pham K; Redd JR; Stephenson EJ; Harvey I; Deng X; Bridges D; Boilard E; Elam MB; Park EA
J Lipid Res; 2017 Sep; 58(9):1822-1833. PubMed ID: 28663239
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2 group IIA expression correlates with prolonged survival in gastric cancer.
Xing XF; Li H; Zhong XY; Zhang LH; Wang XH; Liu YQ; Jia SQ; Shi T; Niu ZJ; Peng Y; Du H; Zhang GG; Hu Y; Lu AP; Li JY; Chen S; Ji JF
Histopathology; 2011 Aug; 59(2):198-206. PubMed ID: 21884198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
